IP Library Granted Patent US 12,708,130
Granted Patent B2
US 12,708,130 · App. 18/318,084 · Granted Aug 18, 2026

Spray-dried composition comprising beta-galactosidase having transgalactosylating activity in combination with maltodextrin and/or NACL and application of the composition

Inventors: Morten Krog Larsen (Sabro, DK); Jens Damgaard (Copenhagen K, DK); Bjarne Larsen (Viby J, DK); Jacob Flyvholm Cramer (Højberg, DK)
Assignee: INTERNATIONAL N&H DENMARK APS
A23L29/06A23C9/1206A23C9/158A23C9/203A23L29/015A23L29/35A23L33/21A23P10/40C12N9/2471C12Y302/01023A23V2002/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,708,130
App. No.
18/318,084
Granted
Aug 18, 2026
Kind
B2
Abstract

A spray-dried composition comprising an enzyme which is a β-galactosidase having transgalactosylating activity and a maltodextrin and/or sodium chloride.

Claims (20)

1 . A spray-dried composition comprising a polypeptide which is a β-galactosidase having transgalactosylating activity wherein the composition comprises:

15-25 wt % maltodextrin, 10-20 wt % sodium chloride, and 0.1 wt % or less polyol,

wherein the spray-dried particles have a volume mean diameter of 50-70 μm,

wherein the polypeptide has a ratio of transgalactosylating activity to β-galactosidase activity of at least 4 at an initial lactose concentration of 3% w/w, wherein the composition retains at least 80% of its initial transgalactosylating activity after 12 months of storage at 25° C.,

and wherein, when the composition is incubated with a lactose-containing milk-based substrate comprising 5% w/w lactose at 37° C. and an enzyme concentration of 100 ppm for 3 hours, the composition produces galacto-oligosaccharides without detectable formation of galactosyl-glycerol.

2 . The composition of claim 1 , wherein the polypeptide having a transgalactosylating activity is selected from the group consisting of:

a. a polypeptide comprising an amino acid sequence having at least 90% sequence identity with SEQ ID NO: 1, wherein said polypeptide consists of at most 980 amino acid residues,

b. a polypeptide comprising an amino acid sequence having at least 97% sequence identity with SEQ ID NO: 2, wherein said polypeptide consists of at most 975 amino acid residues,

c. a polypeptide comprising an amino acid sequence having at least 96.5% sequence identity with SEQ ID NO: 3, wherein said polypeptide consists of at most 1300 amino acid residues,

d. a polypeptide encoded by a polynucleotide that hybridizes under at least low stringency conditions with i) the nucleic acid sequence comprised in SEQ ID NO: 9, 10, 11, 12 or 13 encoding the polypeptide of SEQ ID NO: 1, 2, 3, 4 or 5; or ii) the complementary strand of i),

e. a polypeptide encoded by a polynucleotide comprising a nucleotide sequence having at least 70% identity to the nucleotide sequence encoding for the polypeptide of SEQ ID NO: 1, 2, 3, 4 or 5 or the nucleotide sequence comprised in SEQ ID NO: 9, 10, 11, 12 or 13 encoding a mature polypeptide, and

f. a polypeptide comprising a deletion, insertion and/or conservative substitution of one or more amino acid residues of SEQ ID NO: 1, 2, 3, 4 or 5.

3 . The composition of claim 2 , wherein the polypeptide having transgalactosylating activity is selected from the group consisting of:

a. a polypeptide comprising an amino acid sequence having at least 96.5% sequence identity with SEQ ID NO: 3, wherein said polypeptide consists of at most 1300 amino acid residues,

b. a polypeptide comprising an amino acid sequence having at least 90% sequence identity with SEQ ID NO: 1, wherein said polypeptide consists of at most 980 amino acid residues,

c. a polypeptide encoded by a polynucleotide that hybridizes under at least low stringency conditions with i) the nucleic acid sequence comprised in SEQ ID NO: 9, 10, 11, 12 or 13 encoding the polypeptide of SEQ ID NO: 1, 2, 3, 4, or 5; or ii) the complementary strand of i),

d. a polypeptide encoded by a polynucleotide comprising a nucleotide sequence having at least 70% identity to the nucleotide sequence encoding for the polypeptide of SEQ ID NO: 1, 2, 3, 4 or 5 or the nucleotide sequence comprised in SEQ ID NO: 9, 10, 11, 12 or 13 encoding a mature polypeptide, and

e. a polypeptide comprising a deletion, insertion and/or conservative substitution of one or more amino acid residues of SEQ ID NO: 1, 2, 3, 4 or 5.

4 . The composition of claim 3 , wherein the polypeptide having transgalactosylating activity comprises the amino acid sequence of SEQ ID NO:1, 2, 3, 4 or 5.

5 . The composition of claim 1 , wherein the composition further contains potato starch.